ELAVL1 and hepatocellular carcinoma: Based on ELAVL1 mRNA expression levels in patients with HCC, a gene set enrichment analysis (GSEA) was performed, and the molecular pathways showing more than a 2-fold normalized enrichment score (NES) were represented (Figure 1D).